
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1037 | 958 | 985 | 1049 | 1124 | 1191 |
Fund Return | 3.74% | -4.16% | -1.52% | 1.62% | 2.36% | 1.76% |
Place in category | 55 | 73 | 68 | 109 | 77 | 38 |
% in Category | 35 | 48 | 37 | 58 | 57 | 42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.21B | 0.28 | -0.90 | 4.85 | ||
LU1300848345 | 6.21B | 0.33 | -0.60 | - | ||
LU1323611266 | 3.67B | 4.34 | 0.23 | - | ||
LU1520716801 | 3.67B | 7.31 | 2.63 | - | ||
UBS luxEqSICAV USA Growth USD P Acc | 2.58B | 30.57 | 6.64 | 13.60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Biotech Discovery Nacc | 79.11M | 1.89 | 0.99 | 1.49 | ||
Equities L Biotechnology Class R US | 1.08B | 3.48 | 8.71 | 5.94 | ||
LU0133359157 | 1.08B | 3.53 | 7.41 | 4.64 | ||
Equities L Biotechnology Class I US | 1.08B | 2.92 | 2.58 | 5.59 | ||
Candriam Equities Biotech C USD Cap | 1.08B | 3.56 | 7.84 | 5.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.90 | 484.22 | +1.84% | |
Alnylam | US02043Q1076 | 6.54 | 237.77 | +5.08% | |
AbbVie | US00287Y1091 | 5.52 | 175.05 | +0.49% | |
Neurocrine | US64125C1099 | 5.32 | 90.87 | +0.17% | |
Gilead | US3755581036 | 5.24 | 103.63 | +2.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review